Pet DNA Testing Market: Rising Demand for Advanced Pet Genetic Testing
Driven by humanization of companion animals, rapid advancements in direct-to-consumer (DTC) genomic sequencing, proactive veterinary wellness monitoring, and growing interest in breed ancestry and hereditary risk screening, the companion animal genetics sector is undergoing strong growth. According to market research and industry intelligence by Transpire Insight, the global pet DNA testing market size was valued at USD 412.6 Million in 2025 and is projected to reach USD 972.3 Million by 2033, expanding at a CAGR of 11.50% during the forecast period from 2026 to 2033.
Market Key Figures & Performance Summary
|
Indicator |
Value / Specification |
|
2025 Base Year Market Value |
USD 412.6 Million |
|
2033 Forecast Market Value |
USD 972.3 Million |
|
Forecast CAGR (2026–2033) |
|
|
Dominant Test Type |
Breed Identification (~38% Market Share in 2025) |
|
Dominant Pet Type |
Dogs (Canine Genomics) |
|
Dominant Sample Collection Type |
Saliva / Cheek (Buccal) Swab |
|
Leading Regional Market Share |
North America (~44% Market Share) |
|
Key Market Players |
Wisdom Panel (Mars Petcare), Embark Veterinary, Inc., Basepaws (Zoetis), Neogen Corporation, Orivet Genetic Pet Care, DNA My Dog, Wisdom Health, Genoscoper Laboratories |
Key Market Growth Drivers
- Pet Humanization and Shift Toward Preventive Veterinary Care
Pet owners increasingly treat dogs and cats as integral family members, fueling high demand for personalized health and wellness management. Early screening for inherited mutations—such as Multidrug Resistance 1 (MDR1), Hip Dysplasia markers, and Progressive Retinal Atrophy (PRA)—enables veterinarians and pet parents to tailor diets, medications, and lifestyle choices proactively.
- Convenience and Accessibility of Direct-to-Consumer (DTC) Swab Kits
At-home collection methods using painless cheek (buccal) swabs have drastically lowered entry barriers for consumer genetic testing. Integrated digital portals and mobile applications provide pet owners with easy-to-understand reports on breed composition, physical traits, wild relative matching, and actionable genetic risk factors.
- Expansion into Feline Genomics and Specialty Applications
While canine genetics currently leads market revenue, testing demand for cats is accelerating rapidly through specialized platforms (such as Basepaws). Feline testing offers critical insights into polycystic kidney disease (PKD), hypertrophic cardiomyopathy (HCM), and ancestry traits. Furthermore, equine breed associations, working dog kennels, and commercial breeders utilize DNA testing to prevent inbreeding and confirm lineage.
Market Segmentation Highlights
By Test Type
- Breed Identification & Ancestry: Dominates the market with approximately 38% market share in 2025, favored by shelter adoption networks and mixed-breed pet owners seeking lineage clarity.
- Genetic Health Screening: The fastest-growing product category, analyzing hundreds of disease-associated mutations, drug sensitivities, and carrier statuses.
- Trait & Allergy Testing: High-value niche panels focused on predicting coat characteristics, adult weight, metabolic tendencies, and environmental sensitivity profiles.
By Pet Type
- Dogs (Canine): Holds the majority revenue share, supported by extensive breed databases, long-standing kennel club registration standards, and high DTC kit adoption.
- Cats (Feline): Demonstrating high growth as specialized feline panels gain traction among cat owners and purebred breeders.
- Horses & Other Companion/Exotic Animals: Serves performance horse registries, avian gender/ancestry verification, and exotic animal health management.
By Sample Type
- Saliva / Buccal Swabs: Represents the dominant collection method due to non-invasive home usability and stable ambient room-temperature storage.
- Blood & Tissue Samples: Primarily utilized in clinical veterinary practices, specialized research facilities, and formal livestock/equine diagnostic environments.
Regional Landscape
- North America: Commands the global market with approximately 44% market share, driven by exceptionally high pet ownership rates, substantial disposable expenditure on pet care, and the presence of dominant industry leaders such as Embark and Wisdom Panel.
- Europe: Represents a significant regional market, supported by strong animal welfare regulations, growing veterinary network adoption of health testing, and high purebred pet registration density.
- Asia-Pacific: Anticipated to record the fastest growth rate during the forecast period, fueled by expanding urban pet populations, rising middle-class pet spend, and increasing awareness of genetic health testing across China, Japan, and South Korea.
Top Reports:
https://www.transpireinsight.com/fr/report/italy-gas-turbine-market
https://www.transpireinsight.com/ru/report/italy-gas-turbine-market
https://www.transpireinsight.com/ko/report/united-states-commercial-greenhouse-market
https://www.transpireinsight.com/ar/report/united-states-commercial-greenhouse-market
https://www.transpireinsight.com/he/report/united-states-commercial-greenhouse-market
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Juegos
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness